Abstract
Ana Sofía Vallés, Francisco J. Barrantes
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
High frequency of mitochondrial DNA rearrangements in the peripheral blood of adults with intellectual disability
10.1111/jir.13197 · 2025
Mitochondrial dysfunction in neurodegenerative diseases: mechanisms and corresponding therapeutic strategies
10.3390/biomedicines13020327 · 2025
Postsynaptic autism spectrum disorder genes and synaptic dysfunction
10.1016/j.nbd.2021.105564 · 2022
Alzheimer's disease as a synaptopathy: evidence for dysfunction of synapses during disease progression
10.3389/fnsyn.2023.1129036 · 2023
Autism and dementia: a summative report from the 2nd international summit on intellectual disabilities and dementia
10.1007/s10803-025-06843-7 · 2025
Association between autism and dementia across generations: evidence from a family study of the Swedish population
10.1038/s41380-025-03045-6 · 2025
The prevalence and incidence of early-onset dementia among adults with autism spectrum disorder
10.1002/aur.2590 · 2021
Environmental toxicology and metabolism
10.3390/metabo14100530 · 2024
Bridging environmental exposures and brain health with an integrative framework for understanding neurobiological impacts
10.1016/j.neubiorev.2025.106444 · 2025
The impact of maternal high-fat diet consumption on neural development and behavior of offspring
10.1038/ijosup.2012.15 · 2012
Maternal nutritional programming shapes the cerebral landscape
10.1016/j.tem.2023.10.008 · 2024
Maternal immune activation: A critical prenatal risk factor for autism spectrum disorder
10.1016/j.medj.2025.100967 · 2026
Microenvironment dysregulation in autism spectrum disorder: Immune, epigenetic, synaptic, and gut-brain mechanisms
10.1016/j.medj.2026.101034 · 2026
Early life adversity and health-risk behaviors: proposed psychological and neural mechanisms
10.1111/nyas.13928 · 2018
Epigenetic regulation of brain development, plasticity, and response to early-life stress
10.1038/s41386-025-02179-z · 2026
The role of maternal obesity in the risk of neuropsychiatric disorders
10.3389/fnins.2015.00194 · 2015
Maternal high-fat diet programming of the neuroendocrine system and behavior
10.1016/j.yhbeh.2015.04.008 · 2015
Lipid peroxidation and neuroinflammation: a possible link between maternal fructose intake and delay of acquisition of neonatal reflexes in Wistar female rats
10.1002/dneu.22921 · 2023
Pregestational fructose-induced metabolic syndrome in Wistar rats causes sexually dimorphic behavioral changes in their offspring
10.1002/dneu.22940 · 2024
From maternal metabolism to offspring brain: how high-fructose diets shape neurodevelopment
10.1016/j.tins.2026.03.006 · 2026
Mitochondrial functions modulate neuroendocrine, metabolic, inflammatory, and transcriptional responses to acute psychological stress
10.1073/pnas.1515733112 · 2015
Mitochondrial dysfunction, oxidative stress, and neuroinflammation: intertwined roads to neurodegeneration
10.3390/antiox9080647 · 2020
Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases
10.1016/j.brainresbull.2011.10.004 · 2012
Microglial metabolic reprogramming: emerging insights and therapeutic strategies in neurodegenerative diseases
10.1007/s10571-023-01376-y · 2023
Microglia-orchestrated neuroinflammation and synaptic remodeling: roles of pro-inflammatory cytokines and receptors in neurodegeneration
10.3389/fncel.2025.1700692 · 2025
Brain metabolic stress and neuroinflammation at the basis of cognitive impairment in Alzheimer's disease
10.3389/fnagi.2015.00094 · 2015
The theory of latent vulnerability: Reconceptualizing the link between childhood maltreatment and psychiatric disorder
10.1017/s09545794155 · 2015
Metabolic programming in early life in humans
10.1098/rstb.2018.0123 · 2019
Cognitive synaptopathy: synaptic and dendritic spine dysfunction in age-related cognitive disorders
10.3389/fnagi.2024.1476909 · 2024
Synaptic networks shape clinical phenotypes in neurodevelopmental disorders: an integrative clinical, genetic and biological perspective
10.64898/2026.01.23.701319 · 2026
Epigenetics and the environment: emerging patterns and implications
10.1038/nrg3142 · 2012
Perinatal programming of emotional brain circuits: an integrative view from systems to molecules
10.3389/fnins.2014.00011 · 2014
Epigenetic programming by early-life stress, in Epigenetics and Psychiatric Disease
2018
How early-life programming during embryogenesis imprints cellular memory
10.3390/ijms27010163 · 2025
The hallmarks of aging
10.1016/j.cell.2013.05.039 · 2013
Midlife adiposity predicts earlier onset of Alzheimer's dementia, neuropathology and presymptomatic cerebral amyloid accumulation
10.1038/mp.2015.129 · 2016
Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease
10.1016/j.bbadis.2016.04.017 · 2017
Obesity as a risk factor for Alzheimer's disease: weighing the evidence
10.1111/obr.12629 · 2018
Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums
10.1038/nrneurol.2017.185 · 2018
Cellular Stresses and Stress Responses in the Pathogenesis of Insulin Resistance
10.1155/2018/4321714 · 2018
Structure and function meet at the nicotinic acetylcholine receptor-lipid interface
10.1016/j.phrs.2023.106729 · doi-reference
Synapse-associated neuropathological markers in Alzheimer disease
10.1093/brain/awag117 · doi-reference
Aldose reductase as a key target in the prevention and treatment of diabetic retinopathy: a comprehensive review
10.3390/biomedicines12040747 · doi-reference
A multimodal precision-prevention approach combining lifestyle intervention with metformin repurposing to prevent cognitive impairment and disability: the MET-FINGER randomised controlled trial protocol
10.1186/s13195-023-01355-x · doi-reference
Semaglutide ameliorates cognition and glucose metabolism dysfunction in the 3xTg mouse model of Alzheimer's disease via the GLP-1R/SIRT1/GLUT4 pathway
10.1016/j.neuropharm.2023.109716 · doi-reference
Metformin in the prevention of Alzheimer's disease and Alzheimer's disease related dementias
10.14283/jpad.2023.113 · doi-reference
Oxidative stress in type 2 diabetes: the case for future pediatric redoxomics studies
10.3390/antiox11071336 · doi-reference
Endogenous fructose production: what do we know and how relevant is it?
10.1097/mco.0000000000000573 · doi-reference
Therapeutic targeting of the α7 nicotinic receptor: challenges and prospects for cognitive improvement in Alzheimer's and schizophrenia
10.1111/bcpt.70061 · doi-reference
Autism and α7-nicotinic acetylcholine receptors: new pharmacological and herbal interventions
10.1186/s43094-025-00843-1 · doi-reference
Positive Allosteric modulators of alpha7 nicotinic acetylcholine receptor for the treatment of several central nervous system diseases
10.1021/acsmedchemlett.3c00520 · doi-reference
10.1007/s11011-023-01167-w
10.1007/s11011-023-01167-w · doi-reference
10.1038/s41467-025-61167-5
10.1038/s41467-025-61167-5 · doi-reference
Sphingolipid/cholesterol regulation of neurotransmitter receptor conformation and function
10.1016/j.bbamem.2009.08.016 · doi-reference
Mammalian nicotinic acetylcholine receptors: from structure to function
10.1152/physrev.00015.2008 · doi-reference
Structural basis for lipid modulation of nicotinic acetylcholine receptor function
10.1016/j.brainresrev.2004.06.008 · doi-reference
10.1016/j.nbd.2025.107122
10.1016/j.nbd.2025.107122 · doi-reference
Structural basis of human α7 nicotinic acetylcholine receptor activation
10.1038/s41422-021-00509-6 · doi-reference
Homomeric and heteromeric α7 nicotinic acetylcholine receptors in health and some central nervous system diseases
10.3390/membranes11090664 · doi-reference
Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment
10.1016/j.neuropharm.2014.11.018 · doi-reference
Rodent habenulo-interpeduncular pathway expresses a large variety of uncommon nAChR subtypes, but only the α3β4 and α3β3β4 subtypes mediate acetylcholine release
10.1523/jneurosci.5121-08.2009 · doi-reference
Brain nicotinic acetylcholine receptors: native subtypes and their relevance
10.1016/j.tips.2006.07.004 · doi-reference
The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation
10.1038/sj.bjp.0707264 · doi-reference
Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors
10.1046/j.1471-4159.2004.02347.x · doi-reference
Mitochondrial dysfunction in Alzheimer's disease: role in pathogenesis and novel therapeutic opportunities
10.1111/bph.14585 · doi-reference
Early onset Alzheimer's disease and oxidative stress
10.1155/2014/375968 · doi-reference
Terazosin drives sex-dependent adrenergic–bioenergetic reprogramming to restore network function in Alzheimer's disease
10.64898/2026.04.02.716175 · doi-reference
Neuronal glucose transporter isoform 3 deficient mice demonstrate features of autism spectrum disorders
10.1038/mp.2009.51 · doi-reference
Vascular contributions to Alzheimer's disease
10.1016/j.trsl.2022.12.003 · doi-reference
Pathophysiologic similarities between autism spectrum disorder and Alzheimer's disease: therapeutic possibilities
10.3389/fnins.2025.1737007 · doi-reference
Glycolytic metabolism, brain resilience, and Alzheimer's disease
10.3389/fnins.2021.662242 · doi-reference
Brain fuel metabolism, aging, and Alzheimer's disease
10.1016/j.nut.2010.07.021 · doi-reference
Brain laterality evaluated by F-18 fluorodeoxyglucose positron emission computed tomography in autism spectrum disorders
10.3389/fnmol.2022.901016 · doi-reference
10.3389/fnagi.2018.00425
10.3389/fnagi.2018.00425 · doi-reference
Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease
10.1073/pnas.1317918110 · doi-reference
Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia
10.1073/pnas.2635903100 · doi-reference
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
10.1038/s41583-019-0132-6 · doi-reference
Mitochondria and mitochondrial cascades in Alzheimer's disease
10.3233/jad-170585 · doi-reference
Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline
10.1172/jci59903 · doi-reference
Mechanisms involved in cholesterol-induced neuronal insulin resistance
10.1016/j.neuropharm.2009.05.013 · doi-reference